OBI Pharma, Inc. - 台灣浩鼎生技股份有限公司

2013 The company registered a new English name, "OBI Pharma, Inc." Launch Phase 1 clinical trial for a new generation of carbohydrate cancer immunotherapy in 2014. OBI-833/832 is a new generation cancer vaccine licensed to OBI from Academia Sinica. OBI ..

www.obipharma.com